September 2005 PDF Print E-mail
van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmstrom PO, Collette L, Pierart M, Mirimanoff R, Karim AB; EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council.  
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.
Lancet. 2005 Sep 17;366(9490):985-90.
Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefebvre JL.  
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
Head Neck. 2005 Oct;27(10):843-50.
Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, Shipley WU.  
Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.
JAMA. 2005 Sep 14;294(10):1233-9.
Patt DA, Goodwin JS, Kuo YF, Freeman JL, Zhang DD, Buchholz TA, Hortobagyi GN, Giordano SH.  
Cardiac Morbidity of Adjuvant Radiotherapy for Breast Cancer.
J Clin Oncol. 2005 Sep 12;
Suwinski R, Bankowska-Wozniak M, Majewski W, Sowa A, Idasiak A, Ziolkowska E, Windorbska W, Tarnawski R, Skladowski K, Maciejewski B.  
Randomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: A report on acute normal tissue reactions.
Radiother Oncol. 2005 Sep 9;
Feng M, Jabbari S, Lin A, Bradford CR, Chepeha DB, Teknos TN, Worden FP, Tsien C, Schipper MJ, Wolf GT, Dawson LA, Eisbruch A.  
Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer.
Radiother Oncol. 2005 Sep 7;
Maranzano E, Feyer PC, Molassiotis A, Rossi R, Clark-Snow RA, Olver I, Warr D, Schiavone C, Roila On Behalf Of Participants In The Perugia Consensus Conference 2004 F.  
Evidence-based recommendations for the use of antiemetics in radiotherapy.
Radiother Oncol. 2005 Sep;76(3):227-233.
Masterson TA, Stephenson AJ, Scardino PT, Eastham JA.  
Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
Urology. 2005 Sep;66(3):623-6.
Jani AB, Gratzle J.  
Late radiotherapy toxicity after prostate cancer treatment: influence of hormonal therapy.
Urology. 2005 Sep;66(3):566-70.
Soderdahl DW, Diaz JI, Rabah DM, Schellhammer PF, Fabrizio MD.  
Laparoscopic radical prostatectomy: evaluation of specimen pathologic features to critically assess and modify surgical technique.
Urology. 2005 Sep;66(3):552-6.
Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A; for the Institut Curie Breast Cancer Study Group.  
Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.
Eur J Cancer. 2005 Aug 31;
Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CA.  
Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
J Clin Oncol. 2005 Sep 1;23(25):6199-206.
Patel DA, Presti JC Jr, McNeal JE, Gill H, Brooks JD, King CR.  
Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy.
J Clin Oncol. 2005 Sep 1;23(25):6157-62.
Lukka H, Hayter C, Julian JA, Warde P, Morris WJ, Gospodarowicz M, Levine M, Sathya J, Choo R, Prichard H, Brundage M, Kwan W.  
Randomized trial comparing two fractionation schedules for patients with localized prostate cancer.
J Clin Oncol. 2005 Sep 1;23(25):6132-8.
Birgisson H, Pahlman L, Gunnarsson U, Glimelius B.  
Occurrence of second cancers in patients treated with radiotherapy for rectal cancer.
J Clin Oncol. 2005 Sep 1;23(25):6126-31.
Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.  
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
J Clin Oncol. 2005 Sep 20;23(27):6533-9. Epub 2005 Aug 22.
Voogd AC, van Oost FJ, Rutgers EJ, Elkhuizen PH, van Geel AN, Scheijmans LJ, van der Sangen MJ, Botke G, Hoekstra CJ, Jobsen JJ, van de Velde CJ, von Meyenfeldt MF, Tabak JM, Peterse JL, van de Vijver MJ, Coebergh JW, van Tienhoven G; for the Dutch Study Group on Local Recurrence after Breast Conservation (BORST Group).  
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer.
Eur J Cancer. 2005 Aug 19;
Frata P, Cellai E, Magrini SM, Bonetti B, Vitali E, Tonoli S, Buglione M, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Biti G.  
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two italian radiation oncology centers. II. the case of T2N0 disease.
Int J Radiat Oncol Biol Phys. 2005 Aug 19;
Hong TS, Kriesel KJ, Hartig GK, Harari PM.  
Parotid area lymph node metastases from cutaneous squamous cell carcinoma: Implications for diagnosis, treatment, and prognosis.
Head Neck. 2005 Oct;27(10):851-6.
Chen YJ, Liu A, Tsai PT, Vora NL, Pezner RD, Schultheiss TE, Wong JY.  
Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes.
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):274-81.
Muller K, Nowak PJ, de Pan C, Marijnissen JP, Paridaens DA, Levendag P, Luyten GP.  
Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma.
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):116-22.
Damato B, Kacperek A, Chopra M, Sheen MA, Campbell IR, Errington RD.  
Proton beam radiotherapy of iris melanoma.
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):109-15.
Henson CF, Goldman HW, Rosenwasser RH, Downes MB, Bednarz G, Pequignot EC, Werner-Wasik M, Curran WJ, Andrews DW.  
Glycerol rhizotomy versus gamma knife radiosurgery for the treatment of trigeminal neuralgia: an analysis of patients treated at one institution.
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):82-90.
Tsao MN, Mehta MP, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L.  
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):47-55.
Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L.  
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):37-46.
Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U.  
Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate.
J Clin Oncol. 2005 Aug 20;23(24):5644-50.
Jawahar A, Shaya M, Campbell P, Ampil F, Willis BK, Smith D, Nanda A.  
Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3-6) intracranial metastases.
Surg Neurol. 2005 Sep;64(3):207-12.
Trouncer RJ, Rowbottom CG, Budgell GJ, Mackay RI, Magee B.  
Intensity-modulated radiotherapy planning from limited anatomical information: is Sim-CT sufficient for planning women with breast cancer receiving intensity-modulated radiotherapy?
Clin Oncol (R Coll Radiol). 2005 Aug;17(5):343-51.
Cellai E, Frata P, Magrini SM, Paiar F, Barca R, Fondelli S, Pollim D C, Livi L, Bonetti B, Vitalim D E, De Stefani A, Buglione M, Biti G.  
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two italian radiation oncology centers. I. the case of T1N0 disease.
Int J Radiat Oncol Biol Phys. 2005 Aug 9;
Fournel P, Robinet G, Thomas P, Souquet PJ, Lena H, Vergnenegre A, Delhoume JY, Le Treut J, Silvani JA, Dansin E, Bozonnat MC, Daures JP, Mornex F, Perol M; Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie.  
Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study.
J Clin Oncol. 2005 Sep 1;23(25):5910-7. Epub 2005 Aug 8.
Rhomberg W, Eiter H, Boehler F, Saely C, Strohal R.  
Combined razoxane and radiotherapy for melanoma brain metastases. A retrospective analysis.
J Neurooncol. 2005 Sep;74(3):295-9.
Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rube C, Kirsch CM.  
Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
J Nucl Med. 2005 Aug;46(8):1342-8.
Guadagnolo BA, Haddad RI, Posner MR, Weeks L, Wirth LJ, Norris CM, Sullivan CA, Goguen L, Busse PM, Tishler R.  
Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
Am J Clin Oncol. 2005 Aug;28(4):371-8.
Darby SC, McGale P, Taylor CW, Peto R.  
Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.
Lancet Oncol. 2005 Aug;6(8):557-65.
Schild SE, Wong WW, Vora SA, Halyard MY, Northfelt DW, Kogut HL, Wheeler RH.  
The long-term results of a pilot study of three times a day radiotherapy and escalating doses of daily cisplatin for locally advanced non-small-cell lung cancer.
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1432-7.
Cohen SJ, Dobelbower R Jr, Lipsitz S, Catalano PJ, Sischy B, Smith TJ, Haller DG; Eastern Cooperative Oncology Group.  
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1345-50.
Vass S, Bairati I.  
A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique.
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1274-82.
Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X, Fourquet A.  
Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review.
Cancer. 2005 Aug 15;104(4):856-63.
Mehta V.  
Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):5-24.
Choi Y, Kim JK, Lee HS, Hur WJ, Chai GY, Kang KM.  
Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):683-9. Epub 2005 May 31.
Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z.  
Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):765-71.
Lester JF, Macbeth FR, Coles B.  
Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: A Cochrane Review.
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):690-4.
Stephens RJ, Girling DJ, Hopwood P, Thatcher N; Medical Research Council Lung Cancer Working Party.  
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
Lung Cancer. 2005 Sep;49(3):395-400.

Antoniou D, Kyprianou K, Stathopoulos GP, Skarleas C, Kolitsi G, Veslemes M, Dimitroulis J, Giamboudakis P, Marosis K, Armenaki O, Papageorgiou C, Katis C.  
Response to radiotherapy in brain metastases and survival of patients with non-small cell lung cancer.
Oncol Rep. 2005 Sep;14(3):733-6.
Muacevic A, Siebels M, Tonn JC, Wowra B.  
Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery?
World J Urol. 2005 Sep;23(3):180-4.
 
[ Back ]